Yuanhui Mao

Dr. Yuanhui Mao

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 August 2024 in International Journal of Biological Macromolecules
Verified
Journal Article
Open access
YLYucui Lu
Yucui Lu
LQLinyin Qin
Linyin Qin
YMYuanhui Mao
Yuanhui Mao
XLXianmei Lnong
Xianmei Lnong
QWQianni Wei
Qianni Wei
LZLi-chun Zhao
Li-chun Zhao
The long-term use of antibiotics can cause drug resistance. Natural polysaccharides are a novel means of treating bacterial infections, and the development and utilization of litchi pericarp polysaccharide (LPPs) as a bacteriostatic active substance offer a new research direction for the high-value utilization of litchi by-products. This study revealed that LPPs inhibited Staphylococcus aureus more than Escherichia coli, Listeria monocytogenes, and Salmonella typhimurium, with the minimum inhibitory concentrations of 145, 205, 325, and 445 μg/mL, respectively. The inhibitory activity of LPPs was insignificant for Bacillus subtilis at 505 μg/mL. The assessment of antibacterial mechanisms revealed that LPPs influenced the growth, conductivity, protein, and nucleic acid, reducing sugar, respiratory chain dehydrogenase activity, bacterial lipid peroxidation, intracellular adenosine triphosphate, and extracellular alkaline phosphatase levels of S. aureus. Of note, LPPs could modify the cell wall integrity and cell membrane permeability of S. aureus, resulting in the leakage of intracellular large and small molecules, inhibition of cellular respiratory metabolism, and oxidative losses. These processes exhibited an inhibitory effect and made the bacterium nonfunctional, thereby affecting its growth and metabolism or causing cell death. These findings provide support and insights into the potential application of LPPs as a natural antimicrobial agent.

3 July 2025 in Journal of Trace Elements in Medicine and Biology
Verified
Journal Article
Closed access
YMYuanhui Mao
Yuanhui Mao
LZLishuo Zhang
Lishuo Zhang
CZChengfu Zhang
Chengfu Zhang
LQLinyin Qin
Linyin Qin
XLXiayun Liao
Xiayun Liao
LZLi-chun Zhao
Li-chun Zhao

18 August 2025 in Food Chemistry
Verified
Journal Article
Open access
YLYucui Lu
Yucui Lu
XLXianmei Lnong
Xianmei Lnong
YMYuanhui Mao
Yuanhui Mao
LQLinyin Qin
Linyin Qin
XLXiayun Liao
Xiayun Liao
LZLi-chun Zhao
Li-chun Zhao
Litchi chinensis Sonn. (litchi) pericarp, a major byproduct of litchi processing, is rich in bioactive polysaccharides; however, the structure-bioactivity relationship has not been well studied. Here, a homogenous polysaccharide LPPs-1 was isolated and purified from litchi pericarp, having a weight-average molecular weight of 38.97 kDa (polydispersity index <1.6) and containing the following 9 monosaccharides: L-rhamnose, D-galacturonic acid, D-galactose, L-arabinose, d-glucose, D-xylose, D-mannose, L-fucose, and D-glucuronic acid in a 3.84: 18.55: 13.77: 28.01: 14.06: 9.42: 10.10: 1.18: 1.06 M ratio. NMR spectroscopy identified a → 4)-α-D-GalpA-(1→, →3,6)-β-D-Galp-(1→, and →5)-α-L Araf-(1 → backbone, in a 22.03: 14.06: 10.74 M ratio. Notably, LPPs-1 reversibly inhibited α-amylase (hybrid) and α-glucosidase (uncompetitive) (IC50s: 0.16 mg/mL and 0.24 mg/mL, respectively). The dual enzyme-inhibitory effect of LPPs-1 suggests its potential as a naturally occurring hypoglycemic agent. Our findings indicate the potential of litchi pericarp polysaccharides as a functional food in the management of diabetes.

1 February 2026 in Nutrients
Verified
Journal Article
Open access
PDF file
YZYuanjian Zhong
Yuanjian Zhong
YNYuxiang Nie
Yuxiang Nie
YMYuanhui Mao
Yuanhui Mao
YLYinting Liu
Yinting Liu
TZTong Zou
Tong Zou
LZLichun Zhao
Lichun Zhao
Trace elements are widely involved in fundamental physiological processes, including enzymatic reactions, neurotransmitter metabolism, and redox homeostasis, and their balanced regulation plays an important role in maintaining normal brain development and neurological function. Depression is a complex psychiatric disorder characterized primarily by mood disturbances, with its onset and progression arising from long-term interactions among genetic susceptibility, neurobiological alterations, and environmental factors. A substantial body of epidemiological and clinical evidence indicates that dysregulation of trace elements—such as zinc, selenium, iron, and magnesium—is closely associated with the risk of depression and the severity of depressive symptoms. Mechanistic studies further demonstrate that trace elements influence depression-related pathophysiology through multi-target and multi-pathway mechanisms, including modulation of monoaminergic neurotransmission, neuroinflammation, oxidative stress, mitochondrial energy metabolism, and hypothalamic–pituitary–adrenal axis function. Network pharmacology analyses have additionally identified systemic hub targets, such as albumin (ALB), insulin (INS), and TP53, as well as key pathways including calcium signaling, neuroactive ligand–receptor interactions, and the HIF-1 signaling pathway. These findings suggest that trace elements may regulate depression-related pathological processes through coordinated network-level effects. Collectively, these integrative insights provide a theoretical basis for the application of trace elements in depression risk assessment, the development of precision intervention strategies, and future mechanistic investigations.